These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3291235

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI, Reisman ME, Dawidson I, Toto R, Peters PC, Helderman JH.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS, Veremis SA, Bauma WD, Pollak R, Mozes MF.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP, Frazier OH, Van Buren CT, Duncan JM.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract] [Full Text] [Related]

  • 6. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G, Mihatsch M, Landmann J, Hermle M, Brunner FP, Harder F.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A retrospective analysis of long-term renal allograft function associated with cyclosporine-prednisone immunosuppressive therapy.
    Lewis RM, Janney RP, Van Buren CT, Kerman RH, Herson J, Kerr NA, Golden DA, Kahan BD.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):534-9. PubMed ID: 3291291
    [No Abstract] [Full Text] [Related]

  • 9. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
    Spielberger M, Aigner F, Schmid T, Bösmüller C, Königsrainer A, Margreiter R.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):169-70. PubMed ID: 3291236
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
    Oka T, Omori Y, Aikawa I, Yasumura T, Yoshimura N, Yoshida T.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
    [No Abstract] [Full Text] [Related]

  • 12. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR, Ona ET, Alano FA, Ramos CP, De Luna M.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T, Omori Y, Aikawa I, Yasumura T, Yoshimura N, Nakai I.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract] [Full Text] [Related]

  • 14. Conversion from cyclosporine: status after five years.
    Freedman BI, Tuttle AB, Lorentz WB, Browning MC, Meredith JH, Burkart JM, Adams PL.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1020-2. PubMed ID: 1989144
    [No Abstract] [Full Text] [Related]

  • 15. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY, Zemel SM, Weir MR, Dagher FJ, Bentley FR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
    Belitsky P, MacDonald AS, Cohen AD, Crocker J, Hirsch D, Jindal K, Lawen J.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.
    Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):161-3. PubMed ID: 3291234
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine mono-drug therapy.
    Salaman J.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):117-20. PubMed ID: 3291223
    [Abstract] [Full Text] [Related]

  • 19. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP, Messina M, Colla L, Piccoli GB, Triolo G, Vercellone A.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract] [Full Text] [Related]

  • 20. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
    Carpenter CB, Milford EL, Kirkman RL, Strom TB, Lazarus JM, Tilney NL.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):261-5. PubMed ID: 3927537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.